Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
23
Total Shares
768,194
Total Value
$12,362,718.08
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 10,053 | $1.08 | $10,857.24 | 81,888 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 3,629 | $15.44 | $56,031.76 | 85,517 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 9,347 | $10.20 | $95,339.40 | 94,864 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 20,168 | $16.00 | $322,688.00 | 115,032 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 24,193 | $14.25 | $344,750.25 | 139,225 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Sale | 70,037 | $35.87 | $2,511,919.03 | 69,188 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 28,038 | $1.08 | $30,281.04 | 97,226 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 10,121 | $15.44 | $156,268.24 | 107,347 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 26,069 | $10.20 | $265,903.80 | 133,416 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 53,630 | $16.00 | $858,080.00 | 187,046 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 67,473 | $14.25 | $961,490.25 | 254,519 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 139,245 | $34.83 | $4,849,555.24 | 115,274 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 53,470 | $35.53 | $1,899,553.83 | 61,804 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 2, 2026 | Exercise/Conversion | 10,053 | $0.00 | $0.00 | 72,478 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 2, 2026 | Exercise/Conversion | 3,629 | $0.00 | $0.00 | 16,371 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 2, 2026 | Exercise/Conversion | 9,347 | $0.00 | $0.00 | 160,653 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 2, 2026 | Exercise/Conversion | 20,168 | $0.00 | $0.00 | 84,018 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 2, 2026 | Exercise/Conversion | 24,193 | $0.00 | $0.00 | 175,807 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 5, 2026 | Exercise/Conversion | 28,038 | $0.00 | $0.00 | 44,440 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 5, 2026 | Exercise/Conversion | 10,121 | $0.00 | $0.00 | 6,250 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 5, 2026 | Exercise/Conversion | 26,069 | $0.00 | $0.00 | 134,584 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 5, 2026 | Exercise/Conversion | 53,630 | $0.00 | $0.00 | 30,388 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 5, 2026 | Exercise/Conversion | 67,473 | $0.00 | $0.00 | 108,334 | Direct | โ | View Details |